Subd. 6.Criteria for unsupervised use. (a) To limit the potential for diversion of medication used for the treatment of opioid use disorder to the illicit market, medication dispensed to a client for unsupervised use shall be subject to the requirements of this subdivision. Any client in an opioid treatment program may receive a single unsupervised use dose for a day that the clinic is closed for business, including Sundays and state and federal holidays.(b) A practitioner with authority to prescribe must review and document the criteria in this paragraph and paragraph (c) when determining whether dispensing medication for a client's unsupervised use is appropriate to implement, increase, or extend the amount of time between visits to the program. The criteria are:(1) absence of recent abuse of drugs including but not limited to opioids, non-narcotics, and alcohol;(2) regularity of program attendance;(3) absence of serious behavioral problems at the program;(4) absence of known recent criminal activity such as drug dealing;(5) stability of the client's home environment and social relationships;(6) length of time in comprehensive maintenance treatment;(7) reasonable assurance that unsupervised use medication will be safely stored within the client's home; and(8) whether the rehabilitative benefit the client derived from decreasing the frequency of program attendance outweighs the potential risks of diversion or unsupervised use.(c) The determination, including the basis of the determination must be documented in the client's medical record. see full law